Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha

Analysis of Discordance between Genotypic and Phenotypic Assays for Rifampicin-Resistant <i>Mycobacterium tuberculosis</i> Isolated from Healthcare Facilities in Mthatha

The study sought to determine the rate of discordant results between genotypic and phenotypic tests for the diagnosis of drug-resistant tuberculosis (DR-TB). Sputum samples and cultured isolates from suspected DR-TB patients were, respectively, analyzed for <i>Mycobacterium tuberculosis</i&...

Full description

Bibliographic Details
Main Authors:	Carine Bokop, Lindiwe M. Faye, Teke Apalata
Format:	Article
Language:	English
Published:	MDPI AG 2023-07-01
Series:	Pathogens
Subjects:	Xpert MTB/RIF line probe assay MGIT 960 system <i>Mycobacterium tuberculosis</i> discrepant results
Online Access:	https://www.mdpi.com/2076-0817/12/7/909

Similar Items

Assessment of diagnostic accuracy of Gene Xpert MTB/RIF in diagnosis of suspected retreatment pulmonary tuberculosis patients
by: Takwa E. Meawed, et al.
Published: (2016-07-01)

High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana
by: Justice K Boakye-Appiah, et al.
Published: (2016-01-01)

Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV
by: Edith E. Machowski, et al.
Published: (2021-05-01)

Distribution and frequency of common mutations in rpoB gene of Mycobacterium tuberculosis detected by Xpert MTB/RIF and identification of residential areas of rifampicin resistant-TB cases: A first retrospective study from Mizoram, Northeast India
by: Christine Vanlalbiakdiki Sailo, et al.
Published: (2022-12-01)

An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al.

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
by: Mary Mansfield, et al.
Published: (2022-06-01)

Xpert MTB/RIF for rapid detection of rifampicin-resistant Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia
by: Mulualem Tadesse, et al.
Published: (2016-01-01)

A feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
by: Xichao Ou, et al.
Published: (2015-02-01)

Diagnosis of rifampicin-resistant tuberculosis: Discordant results by diagnostic methods
by: Winnie Mwanza, et al.
Published: (2018-12-01)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
by: F. Bahraminia, et al.
Published: (2021-07-01)

Age and sex distribution of Mycobacterium tuberculosis infection and rifampicin resistance in Myanmar as detected by Xpert MTB/RIF
by: Marva Seifert, et al.
Published: (2021-08-01)

Automated diagnosis of Tuberculosis: A review of advancements
by: EO Shobowale, et al.
Published: (2015-06-01)

Xpert MTB/RIF Ultra Assay Using Stool: an Effective Solution for Bacilli Identification from Adult Pulmonary Tuberculosis Suspects without Expectorated Sputum
by: Xia Yu, et al.
Published: (2023-08-01)

More Than a Decade of GeneXpert<sup>®</sup> <i>Mycobacterium tuberculosis</i>/Rifampicin (Ultra) Testing in South Africa: Laboratory Insights from Twenty-Three Million Tests
by: Manuel Pedro da Silva, et al.
Published: (2023-10-01)

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda
by: Willy Ssengooba, et al.
Published: (2021-12-01)

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia
by: Ayinalem Alemu, et al.
Published: (2020-01-01)

CRISPR-based rapid and ultra-sensitive diagnostic test for Mycobacterium tuberculosis
by: Jing-Wen Ai, et al.
Published: (2019-01-01)

XPERT MTB/RIF TEST FOR THE DIAGNOSIS OF TUBERCULOSIS AND RIFAMPICIN RESISTANCE: RESULTS OF ITS INTRODUCTION IN THE KYRGYZ REPUBLIC
by: A. D. Adambekova, et al.
Published: (2014-01-01)

Role of empiric treatment in hospitalized patients with Xpert MTB/RIF-negative presumptive pulmonary tuberculosis: A prospective cohort study
by: Wakjira Kebede, et al.
Published: (2020-08-01)

Diagnostic Yield of Xpert MTB/RIF Assay Using Bronchoalveolar Lavage Fluid in Detecting <i>Mycobacterium tuberculosis</i> among the Sputum-Scarce Suspected Pulmonary TB Patients
by: Mohammad Khaja Mafij Uddin, et al.
Published: (2022-07-01)

The Role of GeneXpert<sup>®</sup> for Tuberculosis Diagnostics in Brazil: An Examination from a Historical and Epidemiological Perspective
by: Tirça Naiara da Silva Iúdice, et al.
Published: (2023-10-01)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
by: Raksha Rimal, et al.
Published: (2022-04-01)

Are WHO approved nucleic acid amplification tests causing large-scale “false identification” of rifampicin-resistant tuberculosis?: Programmatic experience from south india
by: Praveen Sanker, et al.
Published: (2017-01-01)

Evaluation of GeneXpert MTB/RIF for determination of rifampicin resistance among new tuberculosis cases in west and northwest Iran
by: S. Atashi, et al.
Published: (2017-09-01)

Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data
by: Kamela C. S. Ng, et al.
Published: (2019-08-01)

Diagnostic utility of GeneXpert MTB/RIF assay versus conventional methods for diagnosis of pulmonary and extra-pulmonary tuberculosis
by: Asmaa Mohammed Elbrolosy, et al.
Published: (2021-05-01)

Prevalence of Tuberculosis by Automated GeneXpert Rifampicin Assay and Associated Risk Factors Among Presumptive Pulmonary Tuberculosis Patients at Ataye District Hospital, North East Ethiopia
by: Gebretsadik D, et al.
Published: (2020-05-01)

Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh
by: Samanta Biswas, et al.
Published: (2022-01-01)

Implementation of the Xpert MTB/RIF assay for tuberculosis in Mongolia: a qualitative exploration of barriers and enablers
by: Nicole L. Rendell, et al.
Published: (2017-07-01)

Study of diagnostic utility of Xpert MTB/Rif test on pleural fluid in the evaluation of patients presenting with Pleural Tuberculosis in Nepal
by: Deebya Raj Mishra, et al.
Published: (2022-01-01)

Use of Xpert MTB/RIF for diagnosis of pediatric tuberculosis in Indonesia
by: Rina Triasih, et al.
Published: (2020-07-01)

Epidemiology and outcome of rifampicin resistant tuberculosis in Upper Egypt
by: Shereen Farghaly, et al.
Published: (2021-01-01)

Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimens
by: Weicong Ren, et al.
Published: (2023-02-01)

Discordant results of Xpert MTB/Rif assay and BACTEC MGIT 960 liquid culture to detect Mycobacterium tuberculosis in community screening in Vietnam
by: Hai Viet Nguyen, et al.
Published: (2022-05-01)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
by: Diriba K, et al.
Published: (2021-09-01)

Prevalence of tuberculosis among symptomatic individuals and the risk areas in Ondo State, Nigeria
by: Olatunji Odeyemi, et al.
Published: (2023-12-01)

Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01)

Diagnostic accuracy of GeneXpert MTB/RIF in musculoskeletal tuberculosis: High sensitivity in tissue samples of HIV-infected and HIV-uninfected patients
by: M Held, et al.
Published: (2017-10-01)

The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda
by: A. Andama, et al.
Published: (2021-01-01)

Detection of Mycobacterium tuberculosis Complex Using the Xpert MTB/RIF Ultra Assay on the Stool of Pediatric Patients in Dushanbe, Tajikistan
by: Michael L. Rekart, et al.
Published: (2023-02-01)